Children from 5 to 11 years old may soon be able to get a low-dose COVID-19 vaccine made by Pfizer-BioNTech, as advisors to the U.S. Centers for Disease Control and Prevention (CDC) voted unanimously to recommend the vaccine shots for this age group.

For our comprehensive coverage and latest updates on COVID-19 click here.

"If the recommendations are endorsed by CDC Director Rochelle Walensky, as expected, children could begin getting their shots within the next several days," reported National Public Radio (NPR).

The vaccine is one-third the adult dose and the vaccine would be given in two doses, three weeks apart. The lower dose was chosen to minimize side effects and still produce strong immunity, said Pfizer.

The US Food and Drug Administration (FDA) granted emergency use authorization of the vaccine in 5-11 years old on 29 October. The FDA authorised a 10-microgram dose of Pfizer's vaccine in young children. The original shot was given to those aged 12 and older is 30 micrograms.